Revenue
$11.0B
▲ 11.8% YoY
Net Income
$992.0M
▲ 13.9% YoY
EPS
$8.75
▲ 13.8% YoY
Cash
$420.0M
▼ 23.5% YoY
FY 2025 · As of 2025-12-31
Last 90 days
| Insider | Type | Date | Shares | Price | Value | |
|---|---|---|---|---|---|---|
WENTWORTH TIMOTHY C Director | Grant | Mar 9, 2026 | 215 | $0.00 | $0 | Form 4 ↗ |
Doherty Catherine T. EVP, Regional Businesses | Sell | Mar 5, 2026 | 5.6K | $206.21 | $1.15M | Form 4 ↗ |
PREVOZNIK MICHAEL E SVP & General Counsel | Sell | Mar 5, 2026 | 3.9K | $206.21 | $800K | Form 4 ↗ |
Plewman Patrick SVP for Diagnostic Services | Sell | Mar 5, 2026 | 2.9K | $206.21 | $589K | Form 4 ↗ |
SAMAD SAM Executive Vice President & CFO | Grant | Mar 4, 2026 | 13.9K | $204.86 | $2.86M | Form 4 ↗ |
SAMAD SAM Executive Vice President & CFO | Sell tax | Mar 4, 2026 | 7.7K | $204.86 | $1.58M | Form 4 ↗ |
Doherty Catherine T. EVP, Regional Businesses | Grant | Mar 4, 2026 | 11.4K | $204.86 | $2.33M | Form 4 ↗ |
Doherty Catherine T. EVP, Regional Businesses | Sell tax | Mar 4, 2026 | 5.8K | $204.86 | $1.19M | Form 4 ↗ |
DELANEY MARK E SVP & Chief Commercial Officer | Grant | Mar 4, 2026 | 5.7K | $204.86 | $1.16M | Form 4 ↗ |
DELANEY MARK E SVP & Chief Commercial Officer | Sell tax | Mar 4, 2026 | 2.3K | $204.86 | $477K | Form 4 ↗ |
PREVOZNIK MICHAEL E SVP & General Counsel | Grant | Mar 4, 2026 | 7.2K | $204.86 | $1.48M | Form 4 ↗ |
PREVOZNIK MICHAEL E SVP & General Counsel | Sell tax | Mar 4, 2026 | 3.4K | $204.86 | $687K | Form 4 ↗ |
Davis J. E. CEO and President | Grant | Mar 4, 2026 | 51.7K | $204.86 | $10.58M | Form 4 ↗ |
Davis J. E. CEO and President | Sell tax | Mar 4, 2026 | 26.4K | $204.86 | $5.41M | Form 4 ↗ |
Plewman Patrick SVP for Diagnostic Services | Grant | Mar 4, 2026 | 5.7K | $204.86 | $1.16M | Form 4 ↗ |
Plewman Patrick SVP for Diagnostic Services | Sell tax | Mar 4, 2026 | 2.8K | $204.86 | $579K | Form 4 ↗ |
Deppe Michael J SVP, Corp. Controller & CAO | Grant | Mar 4, 2026 | 1.5K | $204.86 | $302K | Form 4 ↗ |
Deppe Michael J SVP, Corp. Controller & CAO | Sell tax | Mar 4, 2026 | 750 | $204.86 | $154K | Form 4 ↗ |
KUPPUSAMY KARTHIK SVP, Clinical Solutions | Grant | Mar 4, 2026 | 6.2K | $204.86 | $1.27M | Form 4 ↗ |
KUPPUSAMY KARTHIK SVP, Clinical Solutions | Sell | Mar 4, 2026 | 2.6K | $204.86 | $538K | Form 4 ↗ |
Doherty Catherine T. EVP, Regional Businesses | Sell | Mar 3, 2026 | 632 | $207.73 | $131K | Form 4 ↗ |
PREVOZNIK MICHAEL E SVP & General Counsel | Sell | Mar 3, 2026 | 526 | $207.73 | $109K | Form 4 ↗ |
Doherty Catherine T. EVP, Regional Businesses | Sell tax | Mar 2, 2026 | 648 | $204.86 | $133K | Form 4 ↗ |
SAMAD SAM Executive Vice President & CFO | Sell tax | Mar 2, 2026 | 869 | $204.86 | $178K | Form 4 ↗ |
PREVOZNIK MICHAEL E SVP & General Counsel | Sell tax | Mar 2, 2026 | 288 | $204.86 | $59K | Form 4 ↗ |